Disrupting healthcare is an extreme uphill battle, but there are plenty of opportunities to optimize it for a better patient experience.
ShutterStock: Panchenko Vladimir
On the face of it, no industry appears riper for disruption than the U.S. healthcare system.
Healthcare already accounts for close to one-fifth of U.S. GDP and is projected to keep climbing, driven by high prices for hospital care, drugs, and procedures, and by growing demand from an aging, chronically ill population.
Yet performance is mediocre at best. On measures like life expectancy, preventable hospitalizations, maternal mortality, and many chronic-disease outcomes, the U.S. lags behind other developed countries that spend far less.
Millions of U.S. citizens remain uninsured or effectively underinsured, and many who technically have coverage still delay or skip needed care because of cost. For employers, that shows up as absenteeism, presenteeism, and lower productivity; for individuals and households, as financial strain and hard trade-offs.
At the same time, patients’ and providers’ experience with the system is notoriously poor. Patients face access issues, opaque pricing, surprise bills, fragmented records, and difficulty navigating payer networks, while providers are frustrated by the high administrative burden and challenges getting paid for quality care.
In any other industry, this combination of rising costs, uneven quality, and poor user experience would be a clear signal that the market is ripe for disruption. The problem is that U.S. healthcare does not behave like other markets in five fundamental ways.
The dominant payment model remains fee-for-service: providers are paid per visit, test, or procedure. The more they do, the more they earn. The less they do—even when it produces more effective prevention or efficient use of resources—the more revenue they lose.
A hospital’s financial health often depends on admissions, surgeries, imaging, and other high-margin activities. A genuinely disruptive model—say, advanced primary care that keeps people out of the hospital—threatens that revenue, even if it improves outcomes and reduces total system cost. That creates a built-in conflict: many of the innovations we want most as a society undermine the business models of existing institutions.
Policy efforts like “value-based care” have started to shift some contracts toward paying for outcomes and total cost of care. But in many places, these arrangements sit on top of fee-for-service rather than replacing it, so organizations hedge: they experiment with new models while still relying on old-fashioned volume to make the numbers work.
From the outside, healthcare looks like a coherent industry. From the inside, it acts like dozens of different markets stacked on top of one another.
There are multiple major payer types and thousands of commercial and government plans, thousands of provider organizations, specialized intermediaries (e.g., pharmacy benefit managers and payment clearinghouses), and layers of federal and state regulation. Each has its own rules, contracts, and IT systems.
For would-be disrupters, that fragmentation makes scaling much harder. Instead of building one product and selling it into a relatively unified market, they end up negotiating separate deals with each payer, adapting to 50 state regulatory environments, and integrating with multiple electronic health record systems.
Healthcare is highly regulated for good reasons: people’s lives, safety, and privacy are at stake, and large flows of public money are involved. But the way that regulation is structured frustrates innovation and makes it risky.
New models must navigate a thicket of laws on privacy and data security, fraud and abuse, professional licensure, scope of practice, and—in some cases—product approval. Payment adds another layer: if a new service does not fit existing billing codes or coverage rules, it may not get paid at all.
In other industries, it is possible to launch and refine along the way. In healthcare, significant innovation frequently requires years of legal work, pilots, and approvals before would-be disrupters can operate at scale. That long runway eats capital and patience.
Despite the system’s overall dysfunction, many incumbents are profitable. Large health systems, insurers, pharmaceutical and device companies have enjoyed strong financial performance over the past decade. Consolidation has increased their market power: in many regions, a small number of health systems and insurers dominate.
These incumbents are also deeply wired into policymaking and standard-setting. They influence regulations, payment rules, and the data infrastructure newcomers must use. While they certainly feel pressure—from workforce shortages, cyber threats, and political scrutiny—they also have strong incentives to preserve revenue streams that depend on today’s high prices and volumes.
That does not mean incumbents never innovate; many do. But their idea of innovation typically focuses on incremental improvements and revenue-enhancing services, not radical business-model changes that would reshape who gets paid, for what, and how much.
Finally, disruption must address the concerns of those delivering and receiving care.
Clinicians and staff are under intense strain from staffing gaps, burnout, and administrative overload. Any new tool or model that feels like “one more thing to do” will face understandable resistance. At the same time, many patients equate more intervention with better care and may be wary of models that appear to offer “less”—fewer visits, more virtual care, more standardized treatment pathways—even when the evidence is strong.
Disruptive ideas that do not take these cultural dynamics seriously tend to stall at the pilot phase. To change healthcare, you must change how thousands of organizations and millions of professionals work, under heavy pressure and scrutiny. That is a taller order than redesigning a retail experience.
Despite these obstacles, disruption is possible. The pressures that make change necessary—unsustainable cost growth, consumer frustration, and technological progress—also create openings. The most promising approaches share a few common features.
Instead of starting by attacking incumbents’ profit centers, successful disruptors look for segments where someone already benefits financially from lower costs and better outcomes.
Examples include:
In those contexts, a new model that reduces avoidable spending or friction is more likely to be welcomed than resisted.
In healthcare, the “customer” is not a single person.
A solution that delights patients but creates extra work for clinicians will not spread. A model that helps a hospital but raises payer costs will be blocked upstream. Would-be disruptors need a value proposition that creates clear wins for all three groups, or at least avoids obvious losses for any of them.
That usually means doing the hard work of co-design: building with providers and patients, and structuring solutions that convey measurable value to payers, not just new line items.
The health sector does not reward breaking rules. The right mindset is to treat regulation as a design space to work within, not just an obstacle to push against.
That involves understanding early where your model fits into existing categories, where new guidance might be needed, and how to demonstrate safety, efficacy, and privacy protections in ways regulators and institutional partners can trust. It also means planning for long approval cycles and building a runway that can sustain the company through them.
The payoff is resilience: models that fit comfortably within the regulatory environment are far more likely to be adopted by risk-averse institutions and survive policy shifts.
Given the power of existing players, trying to “go around” them entirely is rarely viable at scale. Many successful disruptors instead position themselves as partners who can help incumbents solve real problems: labor shortages, quality gaps, new regulatory requirements, or consumer expectations they struggle to meet alone.
That does not mean abandoning disruptive ambitions. It means structuring partnerships in ways that:
When done well, this kind of collaboration can turn the system’s size from a barrier into a distribution asset.
Finally, any realistic disruption strategy in healthcare has to accept long time horizons. Sales cycles are slow, policy changes are incremental, and organizational change takes years.
Companies that survive and shape the future tend to:
In a complex, politicized sector, clear data and staying power can be as disruptive as any single technology.
The U.S. healthcare system is hard to disrupt, not because it is irrational, but because it is the rational outcome of many overlapping decisions, incentives, and fears.
Fundamentally disrupting it is a very long putt. However, optimizing it in meaningful ways that are beneficial to its key constituencies is possible and can be rewarding on many levels if would-be disruptors are realistic about the scale and complexity of the challenges and have the creativity, patience, and fortitude to overcome them.
此内容由惯性聚合(RSS阅读器)自动聚合整理，仅供阅读参考。 原文来自 — 版权归原作者所有。